Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 1/05/20 → 31/12/21 |
Keywords
- Respiratory medicine
- Idiopathic pulmonary fibrosis
- Clinical trial
Clinical Trial Phase
- Phase II
A randomized, double-blind, dose-ranging, placebo-controlled Phase 2a evaluation of the safety, tolerability and pharmacokinetics of PLN-74809 in participants with idiopathic pulmonary fibrosis.
- Glaspole, Ian (Primary Chief Investigator (PCI))
- Thien, Francis (Chief Investigator (CI))
- Symons, Karen (Project Manager)
Project: Research